GLP-1/Sigma/RAGE receptors: An evolving picture of Alzheimer's disease pathology and treatment.

According to the facts and figures 2023stated that 6.7 million Americans over the age of 65 have Alzheimer's disease (AD). The scenario of AD has reached up to the maximum, of 4.